neurology

News

Cerevel Parkinson’s data adds lustre to AbbVie acquisition

Cerevel Therapeutics’ Parkinson’s disease therapy tavapadon has shown efficacy in a phase 3 trial, reinforcing its blockbuster potential and no doubt delighting AbbVie, wh

News

Ex-broadcaster Paxman hands Parkinson’s wish list to UK PM

To mark World Parkinson’s Day, former broadcaster Jeremy Paxman has delivered a list of recommendations for improving how the disease is managed in the UK to Prime Ministe

News

UK trials will put dementia blood tests through their paces

Researchers in the UK will soon start trialling blood tests that promise to diagnose dementia at clinics across the country in the hope of having them in rout

News

Trial finds benefit for GLP-1 agonist in Parkinson’s

A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for t

News

Leqembi maintenance dose filed in US, but SC form delayed

Eisai has filed to extend the label for its Alzheimer’s disease therapy Leqembi to include a maintenance dosing regimen that would reduce the number of intravenous infusio

News

Dr Jenna Gregory of the University of Aberdeen

Test could give early warning of motor neuron disease

Scientists have developed a new test for a biomarker in brain tissue that could detect people who will go on to develop motor neuron disease (MND) before they show symptom

Cerevel Parkinson’s data adds lustre to AbbVie acquisition

Ex-broadcaster Paxman hands Parkinson’s wish list to UK PM

UK trials will put dementia blood tests through their paces

Trial finds benefit for GLP-1 agonist in Parkinson’s

Leqembi maintenance dose filed in US, but SC form delayed

Test could give early warning of motor neuron disease

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

neurology

Editor's Picks